drugset / Trial / NCT04134442
Improving Pain Management After Total Shoulder Replacement Using Bupivacaine Liposome
RandomizedParallel-groupDouble-blindPrevention
Summary
To improve pain control and decrease opioid requirements for subjects undergoing Total Shoulder Replacement.
Timeline
- Start
- 2019-12-09
- Primary completion
- 2021-09-23
- Completion
- 2021-09-23
Outcome
Outcome not reported
Stopped: “A new large meta-analysis was published. The results showed the likelihood that liposomal bupivacaine and nerve blocks no longer offer significant contribution. Decision was made to terminate the study.”
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Bupivacaine | Other / unclassified | 10 ml | Other |